ArticleCells2022

In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment.

Feifei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.